January 30, 2002Eli Lilly Has Recalled Three Disposable
Insulin Delivery Devices
Indianapolis, IN (SafetyAlerts)
- The Food and Drug Administration (FDA) said that Eli Lilly and Co. has recalled
three disposable insulin delivery devices.
A) Humalog Injection Kits, insulin lispro injection (rDNA origin), 3 ml
disposable insulin delivery device, Recall # D-085-2;
B) Humacart 3/7 Kits, Humalog Pen, 3.0 mL disposable insulin delivery device
(70% human insulin isophane suspension 30% human insulin injection (rDNA
origin)) 100 units per mL., Recall # D-086-2;
C) Humacart R Kits, Humalog Pen (pre-filled) disposable insulin delivery
device, Recall # D-087-2
A) Humalog kits lot FF1E79J;
B) Humacart 3/7 kits; lots FF1J79J and FF1J79N.Exp. 05/2003;
C) Humacart R kits; lots FF1J71K and FFOV67A. Exp. 5/2003 and 9/2003.
Eli Lilly and Co., Indianapolis, IN, by press release on Dec. 3 and 20,
2001. Firm initiated recall is ongoing.
Subpotency (Last dose may deliver less insulin than expected due to breakage
of pen internal parts).
VOLUME OF PRODUCT IN COMMERCE
Approx. 115,000 pens.